1428P Clinical benefit of combination chemo-immunotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic NSCLC

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 34; pp. S813 - S814
Main Authors	Landre, T., Sadaoui, N., Bouharati, D., Taleb, C.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.10.2023
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1016/j.annonc.2023.09.2459